These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22033446)

  • 1. Re: Delay of surgery in men with low risk prostate cancer: D. O'Brien, S. Loeb, G. F. Carvalhal, B. B. McGuire, D. Kan, M. D. Hofer, J. T. Casey, B. T. Helf and W. J. Catalona. J Urol 2011; 185: 2143-2147.
    Klotz L
    J Urol; 2011 Dec; 186(6):2505; author reply 2506. PubMed ID: 22033446
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Delay of surgery in men with low risk prostate cancer: D. O'Brien, S. Loeb, G. F. Carvalhal, B. B. McGuire, D. Kan, M. D. Hofer, J. T. Casey, B. T. Helfand and W. J. Catalona J Urol 2011; 185: 2143-2147.
    Ghosh B; Muruganandham K; Dorairajan LN; Kumar S
    J Urol; 2012 Jul; 188(1):331; author reply 331-2. PubMed ID: 22608754
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer: S. Loeb, M. G. Sanda, D. L. Broyles, S. S. Shin, C. H. Bangma, J. T. Wei, A. W. Partin, G. G. Klee, K. M. Slawin, L. S. Marks, R. H. N. van Schaik, D. W. Chan, L. J. Sokoll, A. B. Cruz, I. A. Mizrahi and W. J. Catalona J Urol 2015;193:1163-1169.
    Shah N; Ioffe V
    J Urol; 2015 Dec; 194(6):1825-6. PubMed ID: 26354886
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer. J. B. Malcolm, M. D. Fabrizio, B. B. Barone, R. W. Given, R. S. Lance, D. F. Lynch, J. W. Davis, M. E. Shaves and P. F. Schellhammer. J Urol 2010; 183: 1822-1828.
    Parker AS
    J Urol; 2011 May; 185(5):1983-4. PubMed ID: 21439591
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system. B. J. Trock, C. C. Guo, M. L. Gonzalgo, A. Magheli, S. Loeb and J. I. Epstein. J Urol 2009; 182: 1364-1370.
    Ikenberg K; Zimmermann AK; Kristiansen G
    J Urol; 2010 May; 183(5):2100; author reply 2100-1. PubMed ID: 20359717
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era: A. S. Kibel, J. P. Ciezki, E. A. Klein, C. A. Reddy, J. D. Lubahn, J. Haslag-minoff, J. O. Deasy, J. M. Michalski, D. Kallogjeri, J. F. Piccirillo, D. M. Rabah, C. Yu, M. W. Kattan And A. J. Stephenson; J Urol 2012; 187: 1259-1265.
    Stenmark MH; Hamstra DA
    J Urol; 2012 Dec; 188(6):2438-9; author reply 2439-40. PubMed ID: 23088984
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. A. J. Stephenson, D. P. Wood, M. W. Kattan, E. A. Klein, P. T. Scardino, J. A. Eastham and B. S. Carver j urol 2009; 182: 1357-1363.
    Calışkan S; Kaya C
    J Urol; 2011 Mar; 185(3):1155. PubMed ID: 21256516
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372.
    See WA
    J Urol; 2010 Oct; 184(4):1573-4; author reply 1574. PubMed ID: 20732691
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease: N. D. Arvold, M. H. Chen, J. W. Moul, B. J. Moran, D. E. Dosoretz, L. L. Bañez, M. J. Katin, M. H. Braccioforte and A. V. D'Amico J Urol 2011; 186: 91-96.
    Trock BJ
    J Urol; 2012 Jan; 187(1):356; author reply 356-7. PubMed ID: 22119358
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: factors associated with the adoption of minimally invasive radical prostatectomy in the United States: w. D. Ulmer, s. M. Prasad, k. J. Kowalczyk, x. Gu, C. Dodgion, s. Lipsitz, g. S. Palapattu, T. K. Choueiri and j. C. Hu j urol 2012; 188: 775-780.
    Witt JH; Zugor V; Labanaris AP
    J Urol; 2013 Mar; 189(3):1169-70. PubMed ID: 23063803
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Zeynep G. Gul, Alberto Martini, and Carl A. Olsson's Letter to the Editor re: Jacob A. Burns, Adam B. Weiner, William J. Catalona, et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol 2019;75:846-52.
    Burns JA; Weiner AB; Kundu S
    Eur Urol; 2019 Oct; 76(4):e99-e100. PubMed ID: 31151679
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy: U. Michl, F. Molfenter, M. Graefen, P. Tennstedt, S. Ahyai, B. Beyer, L. Budäus, A. Haese, H. Heinzer, S. J. Oh, G. Salomon, T. Schlomm, T. Steuber, I. Thederan, H. Huland and D. Tilki J Urol 2015;193:479-483.
    Vehmas T
    J Urol; 2015 Aug; 194(2):595-6. PubMed ID: 25957108
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Use of Phosphodiesterase Type 5 Inhibitors May Adversely Impact Biochemical Recurrence after Radical Prostatectomy: U. Michl, F. Molfenter, M. Graefen, P. Tennstedt, S. Ahyai, B. Beyer, L. Budäus, A. Haese, H. Heinzer, S. J. Oh, G. Salomon, T. Schlomm, T. Steuber, I. Thederan, H. Huland and D. Tilki J Urol 2015;193:479-483.
    Bora GS; Gupta VG; Mavuduru RS
    J Urol; 2016 Mar; 195(3):804; discussion 804-5. PubMed ID: 26627733
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: re: early detection of prostate cancer: AUA guideline: J. W. Moul, P. C. Walsh, M. S. Rendell, H. T. Lynch, S. W. Leslie, O. Kosoko-Lasaki, W. P. Fitzgibbons, I. Powell, A. V. D'Amico and W. J. Catalona J Urol 2013; 190: 1134-1139.
    Shah N; Ioffe V
    J Urol; 2014 Mar; 191(3):871. PubMed ID: 24355135
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories: E. A. Klein, F. J. Bianco, A. M. Serio, J. A. Eastham, M. W. Kattan, J. E. Pontes, A. J. Vickers and P. T. Scardino J Urol 2008; 179: 2212-2217.
    Sivanandam A; Bhandari M
    J Urol; 2008 Dec; 180(6):2716-7; author reply 2717-8. PubMed ID: 18951589
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy: C. Von Bodman, G. Godoy, D. C. Chade, A. Cronin, L. J. Tafe, S. W. Fine, V. Laudone, P. T. Scardino and J. A. Eastham J Urol 2010; 184: 143-148.
    Cai T; Nesi G; Malossini G; Bartoletti R
    J Urol; 2011 Jan; 185(1):360-1; author reply 361. PubMed ID: 21092995
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer CenterS. Carlsson, N. Benfante, R. Alvim, D. D. Sjoberg, A. Vickers, V. E. Reuter, S. W. Fine, H. A. Vargas, M. Wiseman, M. Mamoor, B. Ehdaie, V. Laudone, P. Scardino, J. Eastham and K. Touijer
    Shah N; Ioffe V
    J Urol; 2020 Nov; 204(5):1063-1064. PubMed ID: 32698711
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Limitations of Elastography Based Prostate Biopsy: J. Schiffmann, M. Grindei, Z. Tian, D.-J. Yassin, T. Steinwender, S.-R. Leyh-Bannurah, M. Randazzo, M. Kwiatkowski, P. I. Karakiewicz, P. Hammerer and L. Manka J Urol 2016;195:1731-1736.
    Grey AD; Ahmed HU
    J Urol; 2017 Jan; 197(1):263-264. PubMed ID: 27765703
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach: J. D. Sammon, P. I. Karakiewicz, M. Sun, S. Sukumar, P. Ravi, K. R. Ghani, M. Bianchi, J. O. Peabody, S. F. Shariat, P. Perrotte, J. C. Hu, M. Menon and Q. D. Trinh J Urol 2013; 189: 1289-1294.
    Froehner M; Wirth MP
    J Urol; 2013 Oct; 190(4):1440-1. PubMed ID: 23886883
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. M. Savoie, S. S. Kim and M. S. Soloway. J Urol, 169: 1462-1464, 2003.
    Mondaini N; Gontero P
    J Urol; 2004 Jan; 171(1):359-60; author reply 360. PubMed ID: 14665930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.